HomeTHYROCARE • NSE
add
Thyrocare Technologies Ltd
Nakaraang pagsara
₹878.10
Sakop ng araw
₹868.00 - ₹904.20
Sakop ng taon
₹571.40 - ₹1,055.00
Market cap
47.32B INR
Average na Volume
175.69K
P/E ratio
52.43
Dividend yield
-
Primary exchange
NSE
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (INR) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 1.87B | 21.34% |
Gastos sa pagpapatakbo | 602.90M | 61.94% |
Net na kita | 217.00M | 22.05% |
Net profit margin | 11.59 | 0.52% |
Kita sa bawat share | 4.16 | 17.51% |
EBITDA | 577.45M | 82.58% |
Aktuwal na % ng binabayarang buwis | 54.29% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (INR) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 1.92B | 31.30% |
Kabuuang asset | 6.93B | 7.59% |
Kabuuang sagutin | 1.46B | 25.33% |
Kabuuang equity | 5.47B | — |
Natitirang share | 52.04M | — |
Presyo para makapag-book | 8.36 | — |
Return on assets | — | — |
Return on capital | 20.36% | — |
Cash Flow
Net change in cash
| (INR) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 217.00M | 22.05% |
Cash mula sa mga operasyon | — | — |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | — | — |
Net change in cash | — | — |
Malayang cash flow | — | — |
Tungkol
Thyrocare Technologies Limited is an Indian multinational chain of diagnostic and preventive care laboratories, headquartered in Navi Mumbai. As of 2021, the company has a total of 1,122 outlets and collection centers across India and parts of Nepal, Bangladesh and the Middle East.
On 26 June 2021, Indian e-pharmacy and online healthcare aggregator PharmEasy's parent API Holdings acquired a 66.1% controlling stake in Thyrocare, making Thyrocare the first Indian listed company to be acquired by a startup. Wikipedia
Itinatag
1996
Headquarters
Website
Mga Empleyado
1,693
